These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 4863110)
1. Etiocholanolone in the evaluation of marrow reserves in patients receiving cytotoxic agents. Vogel JM; Kimball HR; Wolff SM; Perry S Ann Intern Med; 1967 Dec; 67(6):1226-38. PubMed ID: 4863110 [No Abstract] [Full Text] [Related]
2. The use of etiocholanolone for the measurement of marrow granulocyte reserves. Gunz FW; Mani MK; Ravich RB; Speden J; Vincent PC Med J Aust; 1970 Apr; 1(15):763-7. PubMed ID: 4914293 [No Abstract] [Full Text] [Related]
3. [Clinical usefulness of eticholanolone in the evaluation of bone marrow reserves in patients treated with myelosuppressive drugs and with radiotherapy]. Marcolongo R; Di Paolo N; Bianco G; Bravi A Haematologica; 1969; 54(9):603-26. PubMed ID: 4994340 [No Abstract] [Full Text] [Related]
5. [Perspectives of neoplasm chemotherapy]. Schmähl D Geburtshilfe Frauenheilkd; 1970 Jan; 30(1):13-24. PubMed ID: 5462035 [No Abstract] [Full Text] [Related]
6. Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents. DeConti RC; Kaplan SR; Calabresi P Blood; 1972 May; 39(5):602-9. PubMed ID: 5067305 [No Abstract] [Full Text] [Related]
7. [Progress in chemotherapy of solid tumors and malignant lymphomas (continued)]. Alberto P Praxis; 1967 Dec; 56(49):1650-1 concl. PubMed ID: 4880021 [No Abstract] [Full Text] [Related]
8. [Determination of bone marrow granulocyte reserves with etiocholanolone in solid tumors and hemoblastosis]. Mayr AC; Jungi WF; Senn HJ; Nagel GA Schweiz Med Wochenschr; 1972 Nov; 102(44):1608-9. PubMed ID: 4509371 [No Abstract] [Full Text] [Related]
9. Correlation of granulocyte mobilization with etiocholanolone and the subsequent development of myelosuppression in patients with acute leukemia receiving therapy. Godwin HA; Zimmerman TS; Kimball HR; Wolff SM; Perry S Blood; 1968 May; 31(5):580-8. PubMed ID: 5239085 [No Abstract] [Full Text] [Related]
10. Cyclophosphamide toxicity in Ugandan and American patients with malignant lymphoma. Brown CH; Ziegler JL; Templeton C; Carbone PP Cancer; 1970 Aug; 26(2):462-7. PubMed ID: 5451221 [No Abstract] [Full Text] [Related]
11. Chemotherapy of the non-Hodgkin's lymphomas. Canellos GP; Lister TA; Skarin AT Cancer; 1978 Aug; 42(2 Suppl):932-40. PubMed ID: 356958 [No Abstract] [Full Text] [Related]
12. The biological properties of etiocholanolone. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med; 1967 Dec; 67(6):1268-95. PubMed ID: 6061942 [No Abstract] [Full Text] [Related]
13. An anti-tumor property of etiocholanolone in man. HELLMAN L; ZUMOFF B; COHN ML; SAKAMOTO A; FRANCIS KC; CLARK DG; FUKUSHIMA DK; GALLAGHER TF Trans Assoc Am Physicians; 1962; 75():321-30. PubMed ID: 13953615 [No Abstract] [Full Text] [Related]
14. Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy. Sherins RJ; DeVita VT Ann Intern Med; 1973 Aug; 79(2):216-20. PubMed ID: 4580112 [No Abstract] [Full Text] [Related]
15. Drug therapy for neoplastic disease in adults. Votaw ML; Bull FE Med Clin North Am; 1969 Nov; 53(6):1265-78. PubMed ID: 4900716 [No Abstract] [Full Text] [Related]
16. The etiocholanolone test for prediction of the leukopenic effect of cytoxic drugs. Karjalainen J; Wasastjerna C Scand J Haematol; 1973; 11(5):337-41. PubMed ID: 4778496 [No Abstract] [Full Text] [Related]
17. A cookbook of anti-cancer chemotherapy for solid tumors. Grady ED; Nolan TR; Crumbley AJ J Med Assoc Ga; 1970 Mar; 59(3):108-15. PubMed ID: 4313674 [No Abstract] [Full Text] [Related]
18. Curative cancer chemotherapy. Frei E Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603 [TBL] [Abstract][Full Text] [Related]